Twist Bioscience (TWST) Other Non-Current Assets (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Other Non-Current Assets data on file, last reported at $5.4 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $5.4 million, up 47.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 million (up 47.14% YoY), and the FY2025 annual result was $4.9 million, up 74.08% from the prior year.
• Other Non-Current Assets climbed to $5.4 million in Q1 2026 per TWST's latest filing, from $2.4 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $5.4 million in Q1 2026 and troughed at $1.6 million in Q1 2022.
• A 5-year average of $3.1 million and a median of $2.8 million in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets sank 67.54% in 2022, then surged 178.56% in 2023.
• A 5-year view of Other Non-Current Assets shows it stood at $2.4 million in 2022, then grew by 18.13% to $2.8 million in 2023, then rose by 21.0% to $3.4 million in 2024, then tumbled by 30.51% to $2.4 million in 2025, then surged by 126.98% to $5.4 million in 2026.
• Business Quant data shows TWST's Other Non-Current Assets at $5.4 million in Q1 2026, $2.4 million in Q4 2025, and $4.9 million in Q3 2025.